Dear members & friends of the CML Advocates Network,
We are thrilled to share with you our contribution to the to VII Simposio anual GELMC!
Our Scientific Project Manager Eglys González-Marcano, talked about the current needs for patients in CML, achieving TFR but also going beyond TFR. The importance of QOL and the use of PROs in Clinical Trials and the regular practice as well as our ongoing projects and activities. Have a closer look at her presentation HERE.
We are pleased to share the launch of the CANCERSurvey 2026, a pan-European patient experience survey led by the European Cancer Organisation (ECO) and WeCanAdvocate. This important initiative aims...
The CML Advocates Network was pleased to participate in the European Hematology Association (EHA) Congress 2026, where members of our community joined leading clinicians, researchers, industry...
At the European Hematology Association (EHA) 2026 Congress, the CML Advocates Network (CMLAN) and Acute Leukemia Advocates Network (ALAN), together with international collaborators, presented new...